Caffeine

SCOTTSDALE, Ariz., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Yerbaé Brands Corp. (TSX-V: YERB.U; OTCQX: YERBF) (“Yerbaé” or the “Company”), a plant-based functional beverage company, today announced a significant expansion of its retail footprint through a new partnership with Casey’s General Stores, one of the largest convenience store chains in the Midwest and Great Plains regions. This agreement will bring Yerbae’s refreshing and functional beverages to over 300 Casey’s locations, marking a key milestone in Yerbae’s growth strategy. Casey's customers across multiple Midwestern states will now have access to Yerbae's popular 12oz SKUs, including Mango Passionfruit, Black Cherry Pineapple, and Peachy Mimosa Twist. This partnership strategically positions Yerbaé to meet demand for healthier, plant-powered energy drinks within the convenience store sector. "Partnering with Casey’s General Stores is a pivotal moment for Yerbae," said Todd Gibson, CEO and Co-Founder of Yerbaé. "Convenience stores are a crucial point of contact for consumers seeking quick, on-the-go refreshment, and this collaboration allows us to deliver our better-for-you energy drinks to a wider audience. We are excited to offer Casey's customers a delicious and natural alternative to traditional sugary options." Founded in 1959, Casey’s General Stores operates more than 2,400 convenience stores across 16 states, serving both urban and rural communities. Renowned for its customer-centric approach and diverse product offerings, including made-from-scratch pizzas and fuel, Casey’s has established itself as a trusted provider of convenience, quality, and value. Expanding Distribution Network Creates Synergies for Safety Shot This expansion into Casey's builds upon Yerbaé's recent successes, including Safety Shot's Inc.’s strategic partnership with 7-Eleven. Safety Shot, which is in the process of acquiring Yerbaé, secured placement of its innovative alcohol-reducing product in 300 7-Eleven stores across the Chicago metropolitan area. Both companies share offices and manufacturing facilities in Scottsdale, Arizona. "The strategic alignment between Yerbaé and Safety Shot is clear," said Jarrett Boon, CEO of Safety Shot. "Our shared commitment to providing consumers with innovative and convenient wellness solutions makes this expansion into Casey's particularly exciting. We believe this partnership will create valuable synergies for both brands and enhance our ability to meet the evolving needs of consumers across the Midwest." Leveraging 7-Eleven's Global Reach The 7-Eleven partnership, which introduced Safety Shot's alcohol-reducing product, Sure Shot, to 300 stores in the Chicago metropolitan area, is particularly significant due to the chain's extensive global footprint. With over 77,000 stores in 17 countries, 7-Eleven provides Safety Shot with access to a massive customer base and unparalleled brand visibility. This strategic alliance leverages 7-Eleven's proven track record of successfully launching beverage brands, including notable successes like Red Bull, Bai, and Celsius. Furthermore, Safety Shot benefits from prime placement within 7-Eleven stores, with prominent counter-top displays that encourage impulse purchases and drive product awareness. This latest distribution agreement with Casey's marks a significant step forward in Yerbaé's ongoing expansion strategy, further solidifying its position as a leader in the functional beverage market while complementing Safety Shot’s innovative crossroads across the United States. Yerbaé Brands Corp. Founded in 2017 by Todd Gibson and Karrie Gibson, Yerbaé Brands Corp., (TSX-V: YERB.U; OTCQX: YERBF) is disrupting the functional beverage marketplace with great tasting, zero sugar, zero calorie beverages, while using plant-based ingredients that are designed to meet the needs of the wellness forward consumer. Harnessing the power of nature, Yerbaé’s key ingredient (yerba mate, a South American herb) is known to produce 196 different vitamins, minerals and nutrients as well as caffeine. By combining yerba mate with its premium ingredients and flavors, Yerbaé provides consumers with a no compromise functional beverage solution. All Yerbaé beverages are zero calorie, zero sugar, non-GMO, and gluten free. Find us @DrinkYerbaé on Instagram, Facebook, Twitter and TikTok, or online at https://yerbae.com. Contact Information: For investors, investors@yerbae.com or 480.471.8391 To reach CEO Todd Gibson, todd@yerbae.com or 480.471.8391 About Safety Shot, Inc. Safety Shot, Inc., a wellness and dietary supplement company, has developed Sure Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy, and overall mood. Sure Shot is available for purchase online at www.sureshot.com, www.walmart.com and Amazon. The Company is introducing business-to-business sales of Sure Shot to distributors, retailers, restaurants, and bars throughout 2025. Investor Relations Phone: 561-244-7100 Email: investors@drinksafetyshot.com Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of the federal securities laws with respect to the proposed business combination between SHOT and Yerbaé. All statements other than statements of historical facts contained in this press release, including statements regarding Pubco’s, SHOT’s or Yerbaé’s future results of operations and financial position, Pubco’s, SHOT’s and Yerbaé’s business strategy, prospective costs, timing and likelihood of success, plans and objectives of management for future operations, future results of current and anticipated operations of Pubco, SHOT and Yerbaé, and the expected value of the combined company after the transactions, are forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to, the following risks relating to the proposed business combination: the risk that the transaction may not be completed in a timely manner or at all, which may adversely affect the price of SHOT’s securities; the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive agreement; the inability to complete the transactions contemplated by the definitive agreement, including due to failure to obtain approval of the shareholders of SHOT or other conditions to closing in the definitive agreement; the inability to obtain or maintain the listing of SHOT ordinary shares on Nasdaq following the business combination; the risk that the transactions contemplated by the business combination disrupt current plans and operations of SHOT as a result of the announcement and consummation of these transactions; the ability to recognize the anticipated benefits of the business combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth economically and hire and retain key employees; costs related to the business combination; changes in applicable laws or regulations; the possibility that Yerbaé or SHOT may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties to be identified in the Registration Statement and accompanying proxy statement/prospectus (when available) relating to the transactions, including those under “Risk Factors” therein, and in other filings with the SEC made by SHOT. Moreover, Yerbaé and SHOT operate in very competitive and rapidly changing environments. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond Yerbaé’s and SHOT’s control, you should not rely on these forward-looking statements as predictions of future events. Forward-looking statements speak only as of the date they are made. None of Yerbaé or SHOT gives any assurance that either Yerbaé or SHOT will achieve its expectations. Readers are cautioned not to put undue reliance on forward-looking statements, and except as required by law, Yerbaé and SHOT assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

题图 | Unsplash 撰文 | 宋文法 2型糖尿病（T2D），是一种常见的慢性疾病，影响全球超过5.4亿人。随着生活和饮食习惯的改变，糖尿病已经成为影响人类健康的第三大因素。在中国，成年人有超过1.14亿糖尿病患者，占全世界糖尿病患者四分之一，在全球范围内居首位，且这一数字仍在继续上升。 咖啡，当代人的续命神器，是世界上最受欢迎的饮料之一。因其含有大量的咖啡因，常被人们饮用以醒神和提高工作效率。过去的研究表明，定期喝咖啡可以带来多种健康益处。 多项研究显示，常喝咖啡与降低2型糖尿病风险相关，然而，尚不清楚在咖啡中添加糖、人工甜味剂、奶油等，是否会改变咖啡降低糖尿病风险的益处。 2025年1月18日，哈佛大学陈曾熙公共卫生学院胡丙长在《美国临床营养学杂志》上发表了一篇题为" Coffee Consumption，Additive Use，and Risk of Type 2 Diabetes-Results from Three Large Prospective US Cohort Studies "的研究论文。 研究显示，每天多喝一杯咖啡（不加任何添加剂），与2型糖尿病风险降低10%相关，而在咖啡中添加糖、人工甜味剂，会让这一关联打折扣，表明糖、人工甜味剂可能会抵消咖啡对糖尿病的益处。 图：参考文献 在这项研究中，研究人员分析了美国三项大型前瞻性队列研究的数据，包括护士健康研究（NHS）、NHS II和健康专业人员随访研究（HPFS），共纳入15万名参与者，通过饮食信息获取了咖啡和咖啡添加剂摄入量信息，包括糖、人工甜味剂、奶油、非乳制咖啡增白剂，分析了咖啡添加剂是否会改变咖啡降低糖尿病风险的益处。 总的来讲，NHS的平均咖啡摄入量为每天2.6杯，NHS II为1.7杯，HPFS为2.1杯，每杯为8盎司（约240毫升）。约有32-42%的参与者经常在咖啡中添加糖，约10%的参与者添加人工甜味剂，不到10%的参与者添加非乳制咖啡增白剂，6%的参与者添加奶油。 汇总分析发现，在不加任何咖啡添加剂的情况下，每多喝一杯咖啡（约240毫升），糖尿病风险降低10%； 在加糖（平均每杯1茶匙，约5克）的情况下，这一关联会减弱，每多喝一杯咖啡，糖尿病风险降低5%； 在加人工甜味剂的情况下，这一关联也会减弱，每多喝一杯咖啡，糖尿病风险降低7%； 添加奶油不会改变咖啡摄入量和糖尿病风险之间的关系，添加非乳制咖啡增白剂时，咖啡摄入量与糖尿病风险没有关联。 同时加糖和人工甜味剂，则与降低糖尿病风险无关。 含不同添加剂的咖啡摄入量与糖尿病风险关联（图：参考文献） 此外，当每天咖啡摄入量超过3杯时，人工甜味剂、非乳制咖啡增白剂会大大减弱咖啡对糖尿病的益处。 研究人员表示，咖啡中的几种生物活性化合物已被证明能抑制与糖尿病发病机制相关的促炎途径，包括绿原酸、葫芦巴碱、咖啡因和酚类化合物等。而添加糖、人工甜味剂会导致体重增加、促炎、糖尿病风险增加等，可以解释抵消了咖啡益处的潜在机制。 值得一提的是，在咖啡中加糖、人工甜味剂，还会抵消咖啡对肝脏的益处。 图：参考文献 2025年1月10日，广州医科大学公共卫生学院的研究人员在" The Journal of Nutrition "期刊上发表了一篇题为" Association of Sugar sweetened，Artificially Sweetened，and Unsweetened Coffee Consumption with Chronic Liver Disease and Liver Related Events：A Large Prospective Cohort Study "的研究论文。 研究显示，适量饮用不加糖、人工甜味剂的咖啡，可显著降低慢性肝病和肝脏相关事件风险，而在咖啡中添加糖、人工甜味剂，则会增加慢性肝病和肝脏相关事件风险。 综上，这项大型前瞻性研究表明，每天多喝一杯咖啡（不加任何添加剂），与2型糖尿病风险降低10%相关，而加糖、人工甜味剂的咖啡会减弱咖啡对糖尿病的保护作用。此外，不加任何添加剂的咖啡还有助于保护肝脏，而加糖、人工甜味剂则会抵消这种益处。 参考文献： https://doi-org.libproxy1.nus.edu.sg/10.1016/j.ajcnut.2025.01.017 https://doi-org.libproxy1.nus.edu.sg/10.1016/j.tjnut.2025.01.009 声明：本文仅做学术分享，不构成任何建议。